BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36686268)

  • 1. High levels of
    Zuo S; Wang H; Zhao Q; Tang J; Wang M; Zhang Y; Sang M; Tian J; Wang P
    Front Integr Neurosci; 2022; 16():1054627. PubMed ID: 36686268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis.
    Shen T; Yue Y; He T; Huang C; Qu B; Lv W; Lai HY
    Front Aging Neurosci; 2021; 13():636545. PubMed ID: 33643026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between increased and decreased gut microbiota abundance and Parkinson's disease: A systematic review and subgroup meta-analysis.
    Bai F; You L; Lei H; Li X
    Exp Gerontol; 2024 Jun; 191():112444. PubMed ID: 38679353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of the relations between gut microbiota and pathogens and Parkinson's disease.
    Zhou S; Li B; Deng Y; Yi J; Mao G; Wang R; Zeng W; Liu B; Wu D; Liu F
    Adv Clin Exp Med; 2023 Jun; 32(6):613-621. PubMed ID: 36881358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota and Its Repercussion in Parkinson's Disease: A Systematic Review in Occidental Patients.
    Proano AC; Viteri JA; Orozco EN; Calle MA; Costa SC; Reyes DV; German-Montenegro M; Moncayo DF; Tobar AC; Moncayo JA
    Neurol Int; 2023 Jun; 15(2):750-763. PubMed ID: 37368331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
    Hill-Burns EM; Debelius JW; Morton JT; Wissemann WT; Lewis MR; Wallen ZD; Peddada SD; Factor SA; Molho E; Zabetian CP; Knight R; Payami H
    Mov Disord; 2017 May; 32(5):739-749. PubMed ID: 28195358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel bacterium
    Isaac RD; Sanjeev K; Subbulakshmi CL; Amirtharaj LV; Sekar M
    J Conserv Dent; 2022; 25(3):297-305. PubMed ID: 35836558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota in patients with Parkinson's disease in southern China.
    Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H
    Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of Bifidobacteriaceae in human hypochlorhydria stomach.
    Mattarelli P; Brandi G; Calabrese C; Fornari F; Prati GM; Biavati B; Sgorbati B
    Microb Ecol Health Dis; 2014; 25():. PubMed ID: 24427111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson's disease.
    Li F; Wang P; Chen Z; Sui X; Xie X; Zhang J
    Neurosci Lett; 2019 Aug; 707():134297. PubMed ID: 31200089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aciduric microbial taxa including Scardovia wiggsiae and Bifidobacterium spp. in caries and caries free subjects.
    Henne K; Rheinberg A; Melzer-Krick B; Conrads G
    Anaerobe; 2015 Oct; 35(Pt A):60-5. PubMed ID: 25933689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Dose Intramuscular Vitamin D3 Supplementation Impacts the Gut Microbiota of Patients With
    Lee SH; Park HK; Kang CD; Choi DH; Park SC; Park JM; Nam SJ; Chae GB; Lee KY; Cho H; Lee SJ
    Front Cell Infect Microbiol; 2022; 12():904987. PubMed ID: 35774395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of inflammatory biomarkers with the diversity of Bacteroidaceae, Bifidobacteriaceae, Prevotellaceae and Lactobacillaceae families in the intestinal microbiota of patients with end stage renal disease.
    Asgharian M; Gholizadeh P; Samadi Kafil H; Ghojazadeh M; Samadi A; Soleymani J; Jouyban A; Tayebi Khosroshahi H
    Adv Med Sci; 2022 Sep; 67(2):304-310. PubMed ID: 35994929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of fecal microbiota in different constipation subtypes and association with colon physiology, lifestyle factors, and psychological status.
    Yu T; Ding Y; Qian D; Lin L; Tang Y
    Therap Adv Gastroenterol; 2023; 16():17562848231154101. PubMed ID: 36875281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered Actinobacteria and Firmicutes Phylum Associated Epitopes in Patients With Parkinson's Disease.
    Li Z; Lu G; Li Z; Wu B; Luo E; Qiu X; Guo J; Xia Z; Zheng C; Su Q; Zeng Y; Chan WY; Su X; Cai Q; Xu Y; Chen Y; Wang M; Poon WS; Luo X
    Front Immunol; 2021; 12():632482. PubMed ID: 34276644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: High levels of
    Zuo S; Wang H; Zhao Q; Tang J; Wang M; Zhang Y; Sang M; Tian J; Wang P
    Front Integr Neurosci; 2023; 17():1229949. PubMed ID: 37529180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of gut microbiota and its correlation with the liver metabolome in the process of ameliorating Parkinson's disease with Buyang Huanwu decoction.
    Hu J; Li P; Zhao H; Ji P; Yang Y; Ma J; Zhao X
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116893. PubMed ID: 37423520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats.
    van Kessel SP; Bullock A; van Dijk G; El Aidy S
    mSystems; 2022 Feb; 7(1):e0119121. PubMed ID: 35076270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of the family bifidobacteriaceae in human dental caries and plaque.
    Modesto M; Biavati B; Mattarelli P
    Caries Res; 2006; 40(3):271-6. PubMed ID: 16707878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Features of gut microbiota in patients with idiopathic Parkinson's disease].
    Li Y; Li RX; Du YT; Xu XJ; Xue Y; Gao D; Gao T; Sheng Z; Zhang LY; Tuo HZ
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1017-1022. PubMed ID: 32294860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.